Epidemiology of childhood acute leukemias

[1] World Health Organization. Cancer today, Estimated number of new cases in 2020, leukemia, both sexes, ages 0–19. . 2023; Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=0&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. World Health Organization Cancer today, Estimated number of new cases in 2020, leukemia, both sexes, ages 0–19 2023 Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=0&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. Search in Google Scholar

[2] Matysiak M. Białaczki u dzieci. Pediatria po dyplomie. 2014; 18: 23–26 MatysiakM Białaczki u dzieci Pediatria po dyplomie 2014 18 23 26 Search in Google Scholar

[3] Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020; 395: 1146–1162 MalardF MohtyM Acute lymphoblastic leukaemia Lancet 2020 395 1146 1162 Search in Google Scholar

[4] Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017; 7: e577 TerwilligerT Abdul-HayM Acute lymphoblastic leukemia: a comprehensive review and 2017 update Blood Cancer J 2017 7 e577 Search in Google Scholar

[5] Metayer C, Milne E, Clavel J, Infante-Rivard C, Petridou E, Taylor M, Schuz J, Spector LG, Dockerty JD, Magnani C, et al. The Childhood Leukemia International Consortium. Cancer Epidemiol. 2013; 37: 336–347 MetayerC MilneE ClavelJ Infante-RivardC PetridouE TaylorM SchuzJ SpectorLG DockertyJD MagnaniC The Childhood Leukemia International Consortium Cancer Epidemiol 2013 37 336 347 Search in Google Scholar

[6] Duffield AS, Mullighan CG, Borowitz MJ. International Consensus Classification of acute lymphoblastic leukemia/lymphoma. Virchows Arch. 2023; 482: 11–26 DuffieldAS MullighanCG BorowitzMJ International Consensus Classification of acute lymphoblastic leukemia/lymphoma Virchows Arch 2023 482 11 26 Search in Google Scholar

[7] Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer. 2013; 60: 728–733 PuumalaSE RossJA AplencR SpectorLG Epidemiology of childhood acute myeloid leukemia Pediatr Blood Cancer 2013 60 728 733 Search in Google Scholar

[8] Cheng J, Sakamot KM. Topics in pediatric leukemia--acute myeloid leukemia. MedGenMed. 2005; 7: 20 ChengJ SakamotKM Topics in pediatric leukemia--acute myeloid leukemia MedGenMed 2005 7 20 Search in Google Scholar

[9] Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022; 140: 1200–1228 ArberDA OraziA HasserjianRP BorowitzMJ CalvoKR KvasnickaHM WangSA BaggA BarbuiT BranfordS International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Blood 2022 140 1200 1228 Search in Google Scholar

[10] World Health Organization. Cancer today, Estimated number of new deaths in 2020, leukemia, both sexes, ages 0–19. 2020; Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=0&cancer=36&type=1&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. World Health Organization Cancer today, Estimated number of new deaths in 2020, leukemia, both sexes, ages 0–19 2020 Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=0&cancer=36&type=1&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. Search in Google Scholar

[11] Tai EW, Ward KC, Bonaventure A, Siegel DA, Coleman MP. Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study. Cancer. 2017; 123 Suppl 24: 5178–5189 TaiEW WardKC BonaventureA SiegelDA ColemanMP Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study Cancer 2017 123 Suppl 24 5178 5189 Search in Google Scholar

[12] Seksarn P, Wiangnon S, Veerakul G, Chotsampancharoen T, Kanjanapongkul S, Chainansamit SO. Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols. Asian Pac J Cancer Prev. 2015; 16: 4609–4614 SeksarnP WiangnonS VeerakulG ChotsampancharoenT KanjanapongkulS ChainansamitSO Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols Asian Pac J Cancer Prev 2015 16 4609 4614 Search in Google Scholar

[13] Demidowicz E, Pogorzala M, Lecka M, Zolnowska H, Marjanska A, Kubicka M, Kurylo-Rafinska B, Czyzewski K, Debski R, Koltan A, et al. Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress. Anticancer Res. 2019; 39: 5203–5207 DemidowiczE PogorzalaM LeckaM ZolnowskaH MarjanskaA KubickaM Kurylo-RafinskaB CzyzewskiK DebskiR KoltanA Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress Anticancer Res 2019 39 5203 5207 Search in Google Scholar

[14] Pui CH, Carroll WL, Meshinchi S, Arceci RJ. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011; 29: 551–565 PuiCH CarrollWL MeshinchiS ArceciRJ Biology, risk stratification, and therapy of pediatric acute leukemias: an update J Clin Oncol 2011 29 551 565 Search in Google Scholar

[15] Balwierz W, Pawinska-Wasikowska K, Klekawka T, Czogala M, Matysiak M, Fic-Sikorska B, Adamkiewicz-Drozynska E, Maciejka-Kapuscinska L, Chybicka A, Potocka K, et al. Development of treatment and clinical results in childhood acute myeloid leukemia in Poland. Memo. 2013; 6: 54–62 BalwierzW Pawinska-WasikowskaK KlekawkaT CzogalaM MatysiakM Fic-SikorskaB Adamkiewicz-DrozynskaE Maciejka-KapuscinskaL ChybickaA PotockaK Development of treatment and clinical results in childhood acute myeloid leukemia in Poland Memo 2013 6 54 62 Search in Google Scholar

[16] World Health Organization. Cancer tomorrow, Changes of new cases from 2020 to 2030. 2023; Available from: https://gco.iarc.fr/tomorrow/en/dataviz/bars?age_end=3&bar_mode=grouped&cancers=36&group_cancers=0&multiple_cancers=0&group_populations=0&populations=991_992_993_994_995_996&key=percent&show_bar_mode_prop=0&years=2030&types=0. World Health Organization Cancer tomorrow, Changes of new cases from 2020 to 2030 2023 Available from: https://gco.iarc.fr/tomorrow/en/dataviz/bars?age_end=3&bar_mode=grouped&cancers=36&group_cancers=0&multiple_cancers=0&group_populations=0&populations=991_992_993_994_995_996&key=percent&show_bar_mode_prop=0&years=2030&types=0. Search in Google Scholar

[17] National Cancer Institute. Surveillance, Epidemiology, and End Results Program, SEER Incidence Rates by Age at Diagnosis, 2016–2020, ages 0–19. 2023; Available from: https://seer.cancer.gov/statistics-network/explorer/application.html?site=92&data_type=1&graph_type=3&compareBy=sex&chk_sex_1=1&hdn_rate_type=1&race=1&advopt_precision=1&advopt_show_ci=on&advopt_show_count=on&hdn_view=1#resultsRegion1. National Cancer Institute Surveillance, Epidemiology, and End Results Program, SEER Incidence Rates by Age at Diagnosis, 2016–2020, ages 0–19 2023 Available from: https://seer.cancer.gov/statistics-network/explorer/application.html?site=92&data_type=1&graph_type=3&compareBy=sex&chk_sex_1=1&hdn_rate_type=1&race=1&advopt_precision=1&advopt_show_ci=on&advopt_show_count=on&hdn_view=1#resultsRegion1. Search in Google Scholar

[18] Hossain MJ, Xie L, McCahan SM. Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis. J Cancer Epidemiol. 2014; 2014: 865979 HossainMJ XieL McCahanSM Characterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosis J Cancer Epidemiol 2014 2014 865979 Search in Google Scholar

[19] Wang Y, Huang J, Rong L, Wu P, Kang M, Zhang X, Lu Q, Fang Y. Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database. Oncotarget. 2016; 7: 83767–83774 WangY HuangJ RongL WuP KangM ZhangX LuQ FangY Impact of age on the survival of pediatric leukemia: an analysis of 15083 children in the SEER database Oncotarget 2016 7 83767 83774 Search in Google Scholar

[20] World Health Organization. Cancer today, Estimated number of new cases in 2020, leukemia, famales, ages 0–19. 2023; Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=2&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. World Health Organization Cancer today, Estimated number of new cases in 2020, leukemia, famales, ages 0–19 2023 Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=2&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. Search in Google Scholar

[21] World Health Organization. Cancer today, Estimated number of new cases in 2020, leukemia, males, ages 0–19. 2023; Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=1&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. World Health Organization Cancer today, Estimated number of new cases in 2020, leukemia, males, ages 0–19 2023 Available from: https://gco.iarc.fr/today/online-analysis-pie?v=2020&mode=population&mode_population=who&population=900&populations=900&key=total&sex=1&cancer=36&type=0&statistic=5&prevalence=0&population_group=2&ages_group%5B%5D=0&ages_group%5B%5D=3&nb_items=7&group_cancer=1&include_nmsc=1&include_nmsc_other=1&population_group_list=32,44,52,84,68,76,152,170,188,192,214,218,222,312,474,254,320,328,332,340,388,484,558,591,600,604,630,662,740,780,858,862&half_pie=0&donut=0&population_group_globocan_id=904. Search in Google Scholar

[22] Kakaje A, Alhalabi MM, Ghareeb A, Karam B, Mansour B, Zahra B, Hamdan O. Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study. Sci Rep. 2020; 10: 6756 KakajeA AlhalabiMM GhareebA KaramB MansourB ZahraB HamdanO Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study Sci Rep 2020 10 6756 Search in Google Scholar

[23] Jaime-Perez JC, Santos J, Gomez-Almaguer D. Childhood T-cell acute lymphoblastic leukemia in a single Latin American center: impact of improved treatment scheme and support therapy on survival. Hematol Transfus Cell Ther. 2020; 42: 320–325 Jaime-PerezJC SantosJ Gomez-AlmaguerD Childhood T-cell acute lymphoblastic leukemia in a single Latin American center: impact of improved treatment scheme and support therapy on survival Hematol Transfus Cell Ther 2020 42 320 325 Search in Google Scholar

[24] Singh SK, Lupo PJ, Scheurer ME, Saxena A, Kennedy AE, Ibrahimou B, Barbieri MA, Mills KI, McCauley JL, Okcu MF, et al. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants. Medicine (Baltimore). 2016; 95: e5300 SinghSK LupoPJ ScheurerME SaxenaA KennedyAE IbrahimouB BarbieriMA MillsKI McCauleyJL OkcuMF A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants Medicine (Baltimore) 2016 95 e5300 Search in Google Scholar

[25] Zhao Y, Wang Y, Ma S. Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology. Sci Rep. 2018; 8: 548 ZhaoY WangY MaS Racial Differences in Four Leukemia Subtypes: Comprehensive Descriptive Epidemiology Sci Rep 2018 8 548 Search in Google Scholar

[26] Oksuzyan S, Crespi CM, Cockburn M, Mezei G, Vergara X, Kheifets L. Race/ethnicity and the risk of childhood leukaemia: a case-control study in California. J Epidemiol Community Health. 2015; 69: 795–802 OksuzyanS CrespiCM CockburnM MezeiG VergaraX KheifetsL Race/ethnicity and the risk of childhood leukaemia: a case-control study in California J Epidemiol Community Health 2015 69 795 802 Search in Google Scholar

[27] Byrne MM, Halman LJ, Koniaris LG, Cassileth PA, Rosenblatt JD, Cheung MC. Effects of poverty and race on outcomes in acute myeloid leukemia. Am J Clin Oncol. 2011; 34: 297–304 ByrneMM HalmanLJ KoniarisLG CassilethPA RosenblattJD CheungMC Effects of poverty and race on outcomes in acute myeloid leukemia Am J Clin Oncol 2011 34 297 304 Search in Google Scholar

[28] Qian M, Xu H, Perez-Andreu V, Roberts KG, Zhang H, Yang W, Zhang S, Zhao X, Smith C, Devidas M, et al. Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics. Blood. 2019; 133: 724–729 QianM XuH Perez-AndreuV RobertsKG ZhangH YangW ZhangS ZhaoX SmithC DevidasM Novel susceptibility variants at the ERG locus for childhood acute lymphoblastic leukemia in Hispanics Blood 2019 133 724 729 Search in Google Scholar

[29] Chokkalingam AP, Hsu LI, Metayer C, Hansen HM, Month SR, Barcellos LF, Wiemels JL, Buffler PA. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics. Cancer Causes Control. 2013; 24: 1789–1795 ChokkalingamAP HsuLI MetayerC HansenHM MonthSR BarcellosLF WiemelsJL BufflerPA Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics Cancer Causes Control 2013 24 1789 1795 Search in Google Scholar

[30] Rosenbaum PF, Buck GM, Brecher ML. Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia. Paediatr Perinat Epidemiol. 2005; 19: 152–164 RosenbaumPF BuckGM BrecherML Allergy and infectious disease histories and the risk of childhood acute lymphoblastic leukaemia Paediatr Perinat Epidemiol 2005 19 152 164 Search in Google Scholar

[31] Mullighan CG. The genomic landscape of acute lymphoblastic leukemia in children and young adults. Hematology Am Soc Hematol Educ Program. 2014; 2014: 174–180 MullighanCG The genomic landscape of acute lymphoblastic leukemia in children and young adults Hematology Am Soc Hematol Educ Program 2014 2014 174 180 Search in Google Scholar

[32] Folley JH, Borges W, Yamawaki T. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med. 1952; 13: 311–321 FolleyJH BorgesW YamawakiT Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan Am J Med 1952 13 311 321 Search in Google Scholar

[33] Abiri B, Kelishadi R, Sadeghi H, Azizi-Soleiman F. Effects of Maternal Diet During Pregnancy on the Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review. Nutr Cancer. 2016; 68: 1065–1072 AbiriB KelishadiR SadeghiH Azizi-SoleimanF Effects of Maternal Diet During Pregnancy on the Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review Nutr Cancer 2016 68 1065 1072 Search in Google Scholar

[34] Haddy N, Le Deley MC, Samand A, Diallo I, Guerin S, Guibout C, Oberlin O, Hawkins M, Zucker JM, de Vathaire F. Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood. Eur J Cancer. 2006; 42: 2757–2764 HaddyN Le DeleyMC SamandA DialloI GuerinS GuiboutC OberlinO HawkinsM ZuckerJM de VathaireF Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood Eur J Cancer 2006 42 2757 2764 Search in Google Scholar

[35] Nino G, Rodriguez-Martinez CE, Gutierrez MJ. Early Microbial-Immune Interactions and Innate Immune Training of the Respiratory System during Health and Disease. Children (Basel). 2021; 8: NinoG Rodriguez-MartinezCE GutierrezMJ Early Microbial-Immune Interactions and Innate Immune Training of the Respiratory System during Health and Disease Children (Basel) 2021 8 Search in Google Scholar

[36] Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015; 282: 20143085 SimonAK HollanderGA McMichaelA Evolution of the immune system in humans from infancy to old age Proc Biol Sci 2015 282 20143085 Search in Google Scholar

[37] Greaves MF. Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia. 1988; 2: 120–125 GreavesMF Speculations on the cause of childhood acute lymphoblastic leukemia Leukemia 1988 2 120 125 Search in Google Scholar

[38] Alexander FE, Chan LC, Lam TH, Yuen P, Leung NK, Ha SY, Yuen HL, Li CK, Lau YL, Greaves MF. Clustering of childhood leukaemia in Hong Kong: association with the childhood peak and common acute lymphoblastic leukaemia and with population mixing. Br J Cancer. 1997; 75: 457–463 AlexanderFE ChanLC LamTH YuenP LeungNK HaSY YuenHL LiCK LauYL GreavesMF Clustering of childhood leukaemia in Hong Kong: association with the childhood peak and common acute lymphoblastic leukaemia and with population mixing Br J Cancer 1997 75 457 463 Search in Google Scholar

[39] Greaves M. A causal mechanism for childhood acute lymphoblastic leukaemia. Nat Rev Cancer. 2018; 18: 471–484 GreavesM A causal mechanism for childhood acute lymphoblastic leukaemia Nat Rev Cancer 2018 18 471 484 Search in Google Scholar

[40] Urayama KY, Ma X, Selvin S, Metayer C, Chokkalingam AP, Wiemels JL, Does M, Chang J, Wong A, Trachtenberg E, et al. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer. 2011; 128: 1632–1643 UrayamaKY MaX SelvinS MetayerC ChokkalingamAP WiemelsJL DoesM ChangJ WongA TrachtenbergE Early life exposure to infections and risk of childhood acute lymphoblastic leukemia Int J Cancer 2011 128 1632 1643 Search in Google Scholar

[41] Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol. 2010; 39: 718–732 UrayamaKY BufflerPA GallagherER AyoobJM MaX A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia Int J Epidemiol 2010 39 718 732 Search in Google Scholar

[42] Gilham C, Peto J, Simpson J, Roman E, Eden TO, Greaves MF, Alexander FE. Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study. BMJ. 2005; 330: 1294 GilhamC PetoJ SimpsonJ RomanE EdenTO GreavesMF AlexanderFE Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study BMJ 2005 330 1294 Search in Google Scholar

[43] Kinlen LJ. Epidemiological evidence for an infective basis in childhood leukaemia. Br J Cancer. 1995; 71: 1–5 KinlenLJ Epidemiological evidence for an infective basis in childhood leukaemia Br J Cancer 1995 71 1 5 Search in Google Scholar

[44] Smith M. Considerations on a possible viral etiology for B-precursor acute lymphoblastic leukemia of childhood. J Immunother. 1997; 20: 89–100 SmithM Considerations on a possible viral etiology for B-precursor acute lymphoblastic leukemia of childhood J Immunother 1997 20 89 100 Search in Google Scholar

[45] Tedeschi R, Bloigu A, Ogmundsdottir HM, Marus A, Dillner J, dePaoli P, Gudnadottir M, Koskela P, Pukkala E, Lehtinen T, et al. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring. Am J Epidemiol. 2007; 165: 134–137 TedeschiR BloiguA OgmundsdottirHM MarusA DillnerJ dePaoliP GudnadottirM KoskelaP PukkalaE LehtinenT Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring Am J Epidemiol 2007 165 134 137 Search in Google Scholar

[46] Kwan ML, Metayer C, Crouse V, Buffler PA. Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring. Am J Epidemiol. 2007; 165: 27–35 KwanML MetayerC CrouseV BufflerPA Maternal illness and drug/medication use during the period surrounding pregnancy and risk of childhood leukemia among offspring Am J Epidemiol 2007 165 27 35 Search in Google Scholar

[47] Jourdan-Da Silva N, Perel Y, Mechinaud F, Plouvier E, Gandemer V, Lutz P, Vannier JP, Lamagnere JL, Margueritte G, Boutard P, et al. Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia. Br J Cancer. 2004; 90: 139–145 Jourdan-Da SilvaN PerelY MechinaudF PlouvierE GandemerV LutzP VannierJP LamagnereJL MargueritteG BoutardP Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia Br J Cancer 2004 90 139 145 Search in Google Scholar

[48] Randolph VL, Heath CW, Jr. Influenza during pregnancy in relation to subsequent childhood leukemia and lymphoma. Am J Epidemiol. 1974; 100: 399–409 RandolphVL HeathCWJr Influenza during pregnancy in relation to subsequent childhood leukemia and lymphoma Am J Epidemiol 1974 100 399 409 Search in Google Scholar

[49] Kinlen LJ. Infection and childhood leukemia. Cancer Causes Control. 1998; 9: 237–239 KinlenLJ Infection and childhood leukemia Cancer Causes Control 1998 9 237 239 Search in Google Scholar

[50] Wartenberg D, Schneider D, Brown S. Childhood leukaemia incidence and the population mixing hypothesis in US SEER data. Br J Cancer. 2004; 90: 1771–1776 WartenbergD SchneiderD BrownS Childhood leukaemia incidence and the population mixing hypothesis in US SEER data Br J Cancer 2004 90 1771 1776 Search in Google Scholar

[51] Clark BR, Ferketich AK, Fisher JL, Ruymann FB, Harris RE, Wilkins JR, 3rd. Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio. Pediatr Blood Cancer. 2007; 49: 797–802 ClarkBR FerketichAK FisherJL RuymannFB HarrisRE WilkinsJR3rd Evidence of population mixing based on the geographical distribution of childhood leukemia in Ohio Pediatr Blood Cancer 2007 49 797 802 Search in Google Scholar

[52] Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci. 2007; 7: 166–175 OremJ MbiddeEK LambertB de SanjoseS WeiderpassE Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology Afr Health Sci 2007 7 166 175 Search in Google Scholar

[53] Guan H, Miao H, Ma N, Lu W, Luo B. Correlations between Epstein-Barr virus and acute leukemia. J Med Virol. 2017; 89: 1453–1460 GuanH MiaoH MaN LuW LuoB Correlations between Epstein-Barr virus and acute leukemia J Med Virol 2017 89 1453 1460 Search in Google Scholar

[54] Telford M, Navarro A, Santpere G. Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin. Sci Rep. 2018; 8: 3472 TelfordM NavarroA SantpereG Whole genome diversity of inherited chromosomally integrated HHV-6 derived from healthy individuals of diverse geographic origin Sci Rep 2018 8 3472 Search in Google Scholar

[55] Luka J, Pirruccello SJ, Kersey JH. HHV-6 genome in T-cell acute lymphoblastic leukaemia. Lancet. 1991; 338: 1277–1278 LukaJ PirruccelloSJ KerseyJH HHV-6 genome in T-cell acute lymphoblastic leukaemia Lancet 1991 338 1277 1278 Search in Google Scholar

[56] Hermouet S, Sutton CA, Rose TM, Greenblatt RJ, Corre I, Garand R, Neves AM, Bataille R, Casey JW. Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma. Leukemia. 2003; 17: 185–195 HermouetS SuttonCA RoseTM GreenblattRJ CorreI GarandR NevesAM BatailleR CaseyJW Qualitative and quantitative analysis of human herpesviruses in chronic and acute B cell lymphocytic leukemia and in multiple myeloma Leukemia 2003 17 185 195 Search in Google Scholar

[57] Salonen MJ, Siimes MA, Salonen EM, Vaheri A, Koskiniemi M. Antibody status to HHV-6 in children with leukaemia. Leukemia. 2002; 16: 716–719 SalonenMJ SiimesMA SalonenEM VaheriA KoskiniemiM Antibody status to HHV-6 in children with leukaemia Leukemia 2002 16 716 719 Search in Google Scholar

[58] Tirado-Rodriguez B, Huerta-Yepez S. Allergies: diseases closely related to cancer. Bol Med Hosp Infant Mex. 2016; 73: 432–445 Tirado-RodriguezB Huerta-YepezS Allergies: diseases closely related to cancer Bol Med Hosp Infant Mex 2016 73 432 445 Search in Google Scholar

[59] Schuz J, Morgan G, Bohler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer. 2003; 105: 255–260 SchuzJ MorganG BohlerE KaatschP MichaelisJ Atopic disease and childhood acute lymphoblastic leukemia Int J Cancer 2003 105 255 260 Search in Google Scholar

[60] Chang JS, Tsai YW, Tsai CR, Wiemels JL. Allergy and risk of childhood acute lymphoblastic leukemia: a population-based and record-based study. Am J Epidemiol. 2012; 176: 970–978 ChangJS TsaiYW TsaiCR WiemelsJL Allergy and risk of childhood acute lymphoblastic leukemia: a population-based and record-based study Am J Epidemiol 2012 176 970 978 Search in Google Scholar

[61] Chang JS, Zhou M, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2011; 20: 1736–1740 ChangJS ZhouM BufflerPA ChokkalingamAP MetayerC WiemelsJL Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia Cancer Epidemiol Biomarkers Prev 2011 20 1736 1740 Search in Google Scholar

[62] Chang JS, Buffler PA, Metayer C, Chokkalingam AP, Patoka J, Kronish D, Wiemels JL. Maternal immunoglobulin E and childhood leukemia. Cancer Epidemiol Biomarkers Prev. 2009; 18: 2221–2227 ChangJS BufflerPA MetayerC ChokkalingamAP PatokaJ KronishD WiemelsJL Maternal immunoglobulin E and childhood leukemia Cancer Epidemiol Biomarkers Prev 2009 18 2221 2227 Search in Google Scholar

[63] Schaub B, Liu J, Hoppler S, Haug S, Sattler C, Lluis A, Illi S, von Mutius E. Impairment of T-regulatory cells in cord blood of atopic mothers. J Allergy Clin Immunol. 2008; 121: 1491–1499, 1499 e1491–1413 SchaubB LiuJ HopplerS HaugS SattlerC LluisA IlliS von MutiusE Impairment of T-regulatory cells in cord blood of atopic mothers J Allergy Clin Immunol 2008 121 1491 1499 1499 e1491–1413 Search in Google Scholar

[64] Amoudruz P, Holmlund U, Malmstrom V, Trollmo C, Bremme K, Scheynius A, Sverremark-Ekstrom E. Neonatal immune responses to microbial stimuli: is there an influence of maternal allergy? J Allergy Clin Immunol. 2005; 115: 1304–1310 AmoudruzP HolmlundU MalmstromV TrollmoC BremmeK ScheyniusA Sverremark-EkstromE Neonatal immune responses to microbial stimuli: is there an influence of maternal allergy? J Allergy Clin Immunol 2005 115 1304 1310 Search in Google Scholar

[65] Eriksson NE, Mikoczy Z, Hagmar L. Cancer incidence in 13811 patients skin tested for allergy. J Investig Allergol Clin Immunol. 2005; 15: 161–166 ErikssonNE MikoczyZ HagmarL Cancer incidence in 13811 patients skin tested for allergy J Investig Allergol Clin Immunol 2005 15 161 166 Search in Google Scholar

[66] Ababou M. Bloom syndrome and the underlying causes of genetic instability. Mol Genet Metab. 2021; 133: 35–48 AbabouM Bloom syndrome and the underlying causes of genetic instability Mol Genet Metab 2021 133 35 48 Search in Google Scholar

[67] Mushtaq N, Wali R, Fadoo Z, Saleem AF. Acute lymphoblastic leukemia in a child with Fanconi’s anaemia. J Coll Physicians Surg Pak. 2012; 22: 458–460 MushtaqN WaliR FadooZ SaleemAF Acute lymphoblastic leukemia in a child with Fanconi’s anaemia J Coll Physicians Surg Pak 2012 22 458 460 Search in Google Scholar

[68] Yetgin S, Tuncer M, Guler E, Duru F, Ali Kasifolu M. Acute lymphoblastic leukemia in Fanconi’s anemia. Am J Hematol. 1994; 45: 94 YetginS TuncerM GulerE DuruF Ali KasifoluM Acute lymphoblastic leukemia in Fanconi’s anemia Am J Hematol 1994 45 94 Search in Google Scholar

[69] Tischkowitz M, Dokal I. Fanconi anaemia and leukaemia - clinical and molecular aspects. Br J Haematol. 2004; 126: 176–191 TischkowitzM DokalI Fanconi anaemia and leukaemia - clinical and molecular aspects Br J Haematol 2004 126 176 191 Search in Google Scholar

[70] Schoenaker MHD, Henriet SS, Zonderland J, van Deuren M, Pan-Hammarstrom Q, Posthumus-van Sluijs SJ, Pico-Knijnenburg I, Weemaes CMR, H IJ. Immunodeficiency in Bloom’s Syndrome. J Clin Immunol. 2018; 38: 35–44 SchoenakerMHD HenrietSS ZonderlandJ van DeurenM Pan-HammarstromQ Posthumus-van SluijsSJ Pico-KnijnenburgI WeemaesCMR IJH Immunodeficiency in Bloom’s Syndrome J Clin Immunol 2018 38 35 44 Search in Google Scholar

[71] Adams M, Jenney M, Lazarou L, White R, Birdsall S, Staab T, Schindler D, Meyer S. Acute myeloid leukaemia after treatment for acute lymphoblastic leukaemia in girl with Bloom syndrome. J Genet Syndr Gene Ther. 2013; 4: AdamsM JenneyM LazarouL WhiteR BirdsallS StaabT SchindlerD MeyerS Acute myeloid leukaemia after treatment for acute lymphoblastic leukaemia in girl with Bloom syndrome J Genet Syndr Gene Ther 2013 4 Search in Google Scholar

[72] Roohi J, Crowe J, Loredan D, Anyane-Yeboa K, Mansukhani MM, Omesi L, Levine J, Revah Politi A, Zha S. New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation. J Hum Genet. 2017; 62: 581–584 RoohiJ CroweJ LoredanD Anyane-YeboaK MansukhaniMM OmesiL LevineJ Revah PolitiA ZhaS New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation J Hum Genet 2017 62 581 584 Search in Google Scholar

[73] Liberzon E, Avigad S, Stark B, Zilberstein J, Freedman L, Gorfine M, Gavriel H, Cohen IJ, Goshen Y, Yaniv I, et al. Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children. Genes Chromosomes Cancer. 2004; 39: 161–166 LiberzonE AvigadS StarkB ZilbersteinJ FreedmanL GorfineM GavrielH CohenIJ GoshenY YanivI Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children Genes Chromosomes Cancer 2004 39 161 166 Search in Google Scholar

[74] Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER, Reinhardt D, Horstmann M, Kaspers GJ, Pieters R, et al. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood. 2008; 111: 4322–4328 BalgobindBV Van VlierbergheP van den OuwelandAM BeverlooHB Terlouw-KromosoetoJN van WeringER ReinhardtD HorstmannM KaspersGJ PietersR Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis Blood 2008 111 4322 4328 Search in Google Scholar

[75] Farah RA, Maalouf F, Chahine NA, Farhat H, Campbell B, Zhukova N, Durno C, Aronson M, Hawkins C, Bouffet E, et al. Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome. Eur J Med Genet. 2019; 62: 103706 FarahRA MaaloufF ChahineNA FarhatH CampbellB ZhukovaN DurnoC AronsonM HawkinsC BouffetE Ongoing issues with the management of children with Constitutional Mismatch Repair Deficiency syndrome Eur J Med Genet 2019 62 103706 Search in Google Scholar

[76] Ripperger T, Beger C, Rahner N, Sykora KW, Bockmeyer CL, Lehmann U, Kreipe HH, Schlegelberger B. Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation. Haematologica. 2010; 95: 841–844 RippergerT BegerC RahnerN SykoraKW BockmeyerCL LehmannU KreipeHH SchlegelbergerB Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation Haematologica 2010 95 841 844 Search in Google Scholar

[77] Schoemaker MJ, Jones ME, Higgins CD, Wright AF, United Kingdom Clinical Cytogenetics G, Swerdlow AJ. Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study. Am J Epidemiol. 2019; 188: 500–508 SchoemakerMJ JonesME HigginsCD WrightAF United Kingdom Clinical Cytogenetics G SwerdlowAJ Mortality and Cancer Incidence in Carriers of Balanced Robertsonian Translocations: A National Cohort Study Am J Epidemiol 2019 188 500 508 Search in Google Scholar

[78] Harrison CJ, Schwab C. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia. Eur J Med Genet. 2016; 59: 162–165 HarrisonCJ SchwabC Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia Eur J Med Genet 2016 59 162 165 Search in Google Scholar

[79] Coktu S, Spix C, Kaiser M, Beygo J, Kleinle S, Bachmann N, Kohlschmidt N, Prawitt D, Beckmann A, Klaes R, et al. Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study. Br J Cancer. 2020; 123: 619–623 CoktuS SpixC KaiserM BeygoJ KleinleS BachmannN KohlschmidtN PrawittD BeckmannA KlaesR Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study Br J Cancer 2020 123 619 623 Search in Google Scholar

[80] Qian M, Cao X, Devidas M, Yang W, Cheng C, Dai Y, Carroll A, Heerema NA, Zhang H, Moriyama T, et al. TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children J Clin Oncol. 2020; 36: 591–599 QianM CaoX DevidasM YangW ChengC DaiY CarrollA HeeremaNA ZhangH MoriyamaT TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children J Clin Oncol 2020 36 591 599 Search in Google Scholar

[81] Frebourg T, Bajalica Lagercrantz S, Oliveira C, Magenheim R, Evans DG. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes Eur J Hum Genet. 2020; 28: 1379–1386 FrebourgT Bajalica LagercrantzS OliveiraC MagenheimR EvansDG Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes Eur J Hum Genet 2020 28 1379 1386 Search in Google Scholar

[82] Rasmussen SA, Overman J, Thomson SA, Colman SD, Abernathy CR, Trimpert RE, Moose R, Virdi G, Roux K, Bauer M, et al. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Genes Chromosomes Cancer. 2000; 28: 425–431 RasmussenSA OvermanJ ThomsonSA ColmanSD AbernathyCR TrimpertRE MooseR VirdiG RouxK BauerM Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1 Genes Chromosomes Cancer 2000 28 425 431 Search in Google Scholar

[83] Pathak A, Pemov A, McMaster ML, Dewan R, Ravichandran S, Pak E, Dutra A, Lee HJ, Vogt A, Zhang X, et al. Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family. Hum Genet. 2015; 134: 775–787 PathakA PemovA McMasterML DewanR RavichandranS PakE DutraA LeeHJ VogtA ZhangX Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family Hum Genet 2015 134 775 787 Search in Google Scholar

[84] Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015; 125: 1083–1090 LocatelliF NiemeyerCM How I treat juvenile myelomonocytic leukemia Blood 2015 125 1083 1090 Search in Google Scholar

[85] Schwartz JR, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, Song G, Wu G, Easton J, Kesserwan C, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017; 8: 1557 SchwartzJR MaJ LamprechtT WalshM WangS BryantV SongG WuG EastonJ KesserwanC The genomic landscape of pediatric myelodysplastic syndromes Nat Commun 2017 8 1557 Search in Google Scholar

[86] Wlodarski MW, Sahoo SS, Niemeyer CM. Monosomy 7 in Pediatric Myelodysplastic Syndromes. Hematol Oncol Clin North Am. 2018; 32: 729–743 WlodarskiMW SahooSS NiemeyerCM Monosomy 7 in Pediatric Myelodysplastic Syndromes Hematol Oncol Clin North Am 2018 32 729 743 Search in Google Scholar

[87] Palma-Barqueros V, Revilla N, Sanchez A, Zamora Canovas A, Rodriguez-Alen A, Marin-Quilez A, Gonzalez-Porras JR, Vicente V, Lozano ML, Bastida JM, et al. Inherited Platelet Disorders: An Updated Overview. Int J Mol Sci. 2021; 22: Palma-BarquerosV RevillaN SanchezA Zamora CanovasA Rodriguez-AlenA Marin-QuilezA Gonzalez-PorrasJR VicenteV LozanoML BastidaJM Inherited Platelet Disorders: An Updated Overview Int J Mol Sci 2021 22 Search in Google Scholar

[88] Warren JT, Di Paola J. Genetics of inherited thrombocytopenias. Blood. 2022; 139: 3264–3277 WarrenJT Di PaolaJ Genetics of inherited thrombocytopenias Blood 2022 139 3264 3277 Search in Google Scholar

[89] Tawana K, Brown AL, Churpek JE. Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges. Br J Haematol. 2022; 196: 1293–1310 TawanaK BrownAL ChurpekJE Integrating germline variant assessment into routine clinical practice for myelodysplastic syndrome and acute myeloid leukaemia: current strategies and challenges Br J Haematol 2022 196 1293 1310 Search in Google Scholar

[90] Farooqui SM, Ward R, Aziz M, Shwachman-Diamond Syndrome, in StatPearls. 2023: Treasure Island (FL). FarooquiSM WardR AzizM Shwachman-Diamond Syndrome in StatPearls 2023 Treasure Island (FL) Search in Google Scholar

[91] Bezzerri V, Cipolli M. Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives. Mol Diagn Ther. 2019; 23: 281–290 BezzerriV CipolliM Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives Mol Diagn Ther 2019 23 281 290 Search in Google Scholar

[92] Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, Kerr E, Zeidler C, Shimamura A, Shah N, et al. Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci. 2011; 1242: 40–55 DrorY DonadieuJ KoglmeierJ DodgeJ Toiviainen-SaloS MakitieO KerrE ZeidlerC ShimamuraA ShahN Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome Ann N Y Acad Sci 2011 1242 40 55 Search in Google Scholar

[93] Bartels M, Bierings M. How I manage children with Diamond-Blackfan anaemia. Br J Haematol. 2019; 184: 123–133 BartelsM BieringsM How I manage children with Diamond-Blackfan anaemia Br J Haematol 2019 184 123 133 Search in Google Scholar

[94] Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment. Semin Thromb Hemost. 2011; 37: 673–681 BallmaierM GermeshausenM Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment Semin Thromb Hemost 2011 37 673 681 Search in Google Scholar

[95] Shah A, Kumar C, Shanmukhaiah C, Rajendran A, Mudaliar S, Idicula-Thomas S, Vundinti BR. Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia. Ann Hematol. 2023; 102: 2683–2693 ShahA KumarC ShanmukhaiahC RajendranA MudaliarS Idicula-ThomasS VundintiBR Genomic and computational analysis of four novel variants of MPL gene in Congenital Amegakaryocytic Thrombocytopenia Ann Hematol 2023 102 2683 2693 Search in Google Scholar

[96] Horwitz MS, Corey SJ, Grimes HL, Tidwell T. ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology. Hematol Oncol Clin North Am. 2013; 27: 19–41, vii HorwitzMS CoreySJ GrimesHL TidwellT ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology Hematol Oncol Clin North Am 2013 27 19 41 vii Search in Google Scholar

[97] Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012; 19: 44–51 ConnellyJA ChoiSW LevineJE Hematopoietic stem cell transplantation for severe congenital neutropenia Curr Opin Hematol 2012 19 44 51 Search in Google Scholar

[98] Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017; 3: 17032 SkokowaJ DaleDC TouwIP ZeidlerC WelteK Severe congenital neutropenias Nat Rev Dis Primers 2017 3 17032 Search in Google Scholar

[99] Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, Oo TH. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2019; 12: 115–118 SimkinsA MaitiA ShortNJ JainN PopatU PatelKP OoTH Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation Hematol Oncol Stem Cell Ther 2019 12 115 118 Search in Google Scholar

[100] Maserati E, Panarello C, Morerio C, Valli R, Pressato B, Patitucci F, Tassano E, Di Cesare-Merlone A, Cugno C, Balduini CL, et al. Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498). Haematologica. 2008; 93: 1271–1273 MaseratiE PanarelloC MorerioC ValliR PressatoB PatitucciF TassanoE Di Cesare-MerloneA CugnoC BalduiniCL Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498) Haematologica 2008 93 1271 1273 Search in Google Scholar

[101] Agarwal N, Spahr JE, Werner TL, Newton DL, Rodgers GM. Acquired amegakaryocytic thrombocytopenic purpura. Am J Hematol. 2006; 81: 132–135 AgarwalN SpahrJE WernerTL NewtonDL RodgersGM Acquired amegakaryocytic thrombocytopenic purpura Am J Hematol 2006 81 132 135 Search in Google Scholar

[102] Young NS. Aplastic Anemia. N Engl J Med. 2018; 379: 1643–1656 YoungNS Aplastic Anemia N Engl J Med 2018 379 1643 1656 Search in Google Scholar

[103] Heuser M, Schlarmann C, Dobbernack V, Panagiota V, Wiehlmann L, Walter C, Beier F, Ziegler P, Yun H, Kade S, et al. Genetic characterization of acquired aplastic anemia by targeted sequencing. Haematologica. 2014; 99: e165–167 HeuserM SchlarmannC DobbernackV PanagiotaV WiehlmannL WalterC BeierF ZieglerP YunH KadeS Genetic characterization of acquired aplastic anemia by targeted sequencing Haematologica 2014 99 e165 167 Search in Google Scholar

[104] Tichelli A, Schrezenmeier H, Socie G, Marsh J, Bacigalupo A, Duhrsen U, Franzke A, Hallek M, Thiel E, Wilhelm M, et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2011; 117: 4434–4441 TichelliA SchrezenmeierH SocieG MarshJ BacigalupoA DuhrsenU FranzkeA HallekM ThielE WilhelmM A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation Blood 2011 117 4434 4441 Search in Google Scholar

[105] Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009; 113: 6549–6557 AlterBP GiriN SavageSA RosenbergPS Cancer in dyskeratosis congenita Blood 2009 113 6549 6557 Search in Google Scholar

[106] Kirschner M, Maurer A, Wlodarski MW, Ventura Ferreira MS, Bouillon AS, Halfmeyer I, Blau W, Kreuter M, Rosewich M, Corbacioglu S, et al. Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita. Leukemia. 2018; 32: 1762–1767 KirschnerM MaurerA WlodarskiMW Ventura FerreiraMS BouillonAS HalfmeyerI BlauW KreuterM RosewichM CorbaciogluS Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita Leukemia 2018 32 1762 1767 Search in Google Scholar

[107] Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, Greaves M. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature. 1993; 363: 358–360 FordAM RidgeSA CabreraME MahmoudH SteelCM ChanLC GreavesM In utero rearrangements in the trithorax-related oncogene in infant leukaemias Nature 1993 363 358 360 Search in Google Scholar

[108] Chuk MK, McIntyre E, Small D, Brown P. Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin. Blood. 2009; 113: 6691–6694 ChukMK McIntyreE SmallD BrownP Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twin Blood 2009 113 6691 6694 Search in Google Scholar

[109] Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2015; 373: 1541–1552 HungerSP MullighanCG Acute Lymphoblastic Leukemia in Children N Engl J Med 2015 373 1541 1552 Search in Google Scholar

[110] Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer. 2009; 124: 2658–2670 CaugheyRW MichelsKB Birth weight and childhood leukemia: a meta-analysis and review of the current evidence Int J Cancer 2009 124 2658 2670 Search in Google Scholar

[111] Kwan ML, Jensen CD, Block G, Hudes ML, Chu LW, Buffler PA. Maternal diet and risk of childhood acute lymphoblastic leukemia. Public Health Rep. 2009; 124: 503–514 KwanML JensenCD BlockG HudesML ChuLW BufflerPA Maternal diet and risk of childhood acute lymphoblastic leukemia Public Health Rep 2009 124 503 514 Search in Google Scholar

[112] World Health Organization. Daily iron and folic acid supplementation in pregnant women. 2020; Available from: http://apps.who.int/iris/bitstream/handle/10665/77770/9789241501996_eng.pdf. World Health Organization Daily iron and folic acid supplementation in pregnant women 2020 Available from: http://apps.who.int/iris/bitstream/handle/10665/77770/9789241501996_eng.pdf. Search in Google Scholar

[113] Metayer C, Milne E, Dockerty JD, Clavel J, Pombo-de-Oliveira MS, Wesseling C, Spector LG, Schuz J, Petridou E, Ezzat S, et al. Maternal supplementation with folic acid and other vitamins and risk of leukemia in offspring: a Childhood Leukemia International Consortium study. Epidemiology. 2014; 25: 811–822 MetayerC MilneE DockertyJD ClavelJ Pombo-de-OliveiraMS WesselingC SpectorLG SchuzJ PetridouE EzzatS Maternal supplementation with folic acid and other vitamins and risk of leukemia in offspring: a Childhood Leukemia International Consortium study Epidemiology 2014 25 811 822 Search in Google Scholar

[114] Milne E, Royle JA, Miller M, Bower C, de Klerk NH, Bailey HD, van Bockxmeer F, Attia J, Scott RJ, Norris MD, et al. Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring. Int J Cancer. 2010; 126: 2690–2699 MilneE RoyleJA MillerM BowerC de KlerkNH BaileyHD van BockxmeerF AttiaJ ScottRJ NorrisMD Maternal folate and other vitamin supplementation during pregnancy and risk of acute lymphoblastic leukemia in the offspring Int J Cancer 2010 126 2690 2699 Search in Google Scholar

[115] Wilson RD, O’Connor DL. Maternal folic acid and multivitamin supplementation: International clinical evidence with considerations for the prevention of folate-sensitive birth defects. Prev Med Rep. 2021; 24: 101617 WilsonRD O’ConnorDL Maternal folic acid and multivitamin supplementation: International clinical evidence with considerations for the prevention of folate-sensitive birth defects Prev Med Rep 2021 24 101617 Search in Google Scholar

[116] Lokossou GAG, Kouakanou L, Schumacher A, Zenclussen AC. Human Breast Milk: From Food to Active Immune Response With Disease Protection in Infants and Mothers. Front Immunol. 2022; 13: 849012 LokossouGAG KouakanouL SchumacherA ZenclussenAC Human Breast Milk: From Food to Active Immune Response With Disease Protection in Infants and Mothers Front Immunol 2022 13 849012 Search in Google Scholar

[117] Walker WA, Iyengar RS. Breast milk, microbiota, and intestinal immune homeostasis. Pediatr Res. 2015; 77: 220–228 WalkerWA IyengarRS Breast milk, microbiota, and intestinal immune homeostasis Pediatr Res 2015 77 220 228 Search in Google Scholar

[118] Gong QQ, Quan DD, Guo C, Zhang C, Zhang ZJ. Association between maternal breastfeeding and risk of systemic neoplasms of offspring. Ital J Pediatr. 2022; 48: 98 GongQQ QuanDD GuoC ZhangC ZhangZJ Association between maternal breastfeeding and risk of systemic neoplasms of offspring Ital J Pediatr 2022 48 98 Search in Google Scholar

[119] Amitay EL, Keinan-Boker L. Breastfeeding and Childhood Leukemia Incidence--Reply. JAMA Pediatr. 2015; 169: 1071–1072 AmitayEL Keinan-BokerL Breastfeeding and Childhood Leukemia Incidence--Reply JAMA Pediatr 2015 169 1071 1072 Search in Google Scholar

[120] Turner MC, Wigle DT, Krewski D. Residential pesticides and childhood leukemia: a systematic review and meta-analysis. Environ Health Perspect. 2009; 118: 33–41 TurnerMC WigleDT KrewskiD Residential pesticides and childhood leukemia: a systematic review and meta-analysis Environ Health Perspect 2009 118 33 41 Search in Google Scholar

[121] Brondum J, Shu XO, Steinbuch M, Severson RK, Potter JD, Robison LL. Parental cigarette smoking and the risk of acute leukemia in children. Cancer. 1999; 85: 1380–1388 BrondumJ ShuXO SteinbuchM SeversonRK PotterJD RobisonLL Parental cigarette smoking and the risk of acute leukemia in children Cancer 1999 85 1380 1388 Search in Google Scholar

[122] Shu XO, Ross JA, Pendergrass TW, Reaman GH, Lampkin B, Robison LL. Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study. J Natl Cancer Inst. 1996; 88: 24–31 ShuXO RossJA PendergrassTW ReamanGH LampkinB RobisonLL Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study J Natl Cancer Inst 1996 88 24 31 Search in Google Scholar

[123] Ognjanovic S, Blair C, Spector LG, Robison LL, Roesler M, Ross JA. Analgesic use during pregnancy and risk of infant leukaemia: a Children’s Oncology Group study. Br J Cancer. 2011; 104: 532–536 OgnjanovicS BlairC SpectorLG RobisonLL RoeslerM RossJA Analgesic use during pregnancy and risk of infant leukaemia: a Children’s Oncology Group study Br J Cancer 2011 104 532 536 Search in Google Scholar

[124] Momen NC, Munk-Olsen T, Li J, Ingstrup KG, Olsen J, Bergink V, Liu X. Antidepressant use during pregnancy and childhood cancer in the offspring. Pharmacoepidemiol Drug Saf. 2018; 27: 114–118 MomenNC Munk-OlsenT LiJ IngstrupKG OlsenJ BerginkV LiuX Antidepressant use during pregnancy and childhood cancer in the offspring Pharmacoepidemiol Drug Saf 2018 27 114 118 Search in Google Scholar

[125] Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Van Loo P, Alexandrov LB, Ramakrishna M, Davies H, et al. Mutational signatures of ionizing radiation in second malignancies. Nat Commun. 2016; 7: 12605 BehjatiS GundemG WedgeDC RobertsND TarpeyPS CookeSL Van LooP AlexandrovLB RamakrishnaM DaviesH Mutational signatures of ionizing radiation in second malignancies Nat Commun 2016 7 12605 Search in Google Scholar

[126] Nikkila A, Raitanen J, Lohi O, Auvinen A. Radiation exposure from computerized tomography and risk of childhood leukemia: Finnish register-based case-control study of childhood leukemia (FRECCLE). Haematologica. 2018; 103: 1873–1880 NikkilaA RaitanenJ LohiO AuvinenA Radiation exposure from computerized tomography and risk of childhood leukemia: Finnish register-based case-control study of childhood leukemia (FRECCLE) Haematologica 2018 103 1873 1880 Search in Google Scholar

[127] Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997; 70: 130–139 DollR WakefordR Risk of childhood cancer from fetal irradiation Br J Radiol 1997 70 130 139 Search in Google Scholar

[128] Nottage K, Lanctot J, Li Z, Neglia JP, Bhatia S, Hammond S, Leisenring W, Meadows A, Srivastava D, Robison LL, et al. Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study. Blood. 2011; 117: 6315–6318 NottageK LanctotJ LiZ NegliaJP BhatiaS HammondS LeisenringW MeadowsA SrivastavaD RobisonLL Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study Blood 2011 117 6315 6318 Search in Google Scholar

[129] Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res. 2000; 6: 4091–4095 NaoeT TakeyamaK YokozawaT KiyoiH SetoM UikeN InoT UtsunomiyaA MarutaA Jin-naiI Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia Clin Cancer Res 2000 6 4091 4095 Search in Google Scholar

[130] Ron E, Modan B, Boice JD, Jr. Mortality after radiotherapy for ringworm of the scalp. Am J Epidemiol. 1988; 127: 713–725 RonE ModanB BoiceJDJr Mortality after radiotherapy for ringworm of the scalp Am J Epidemiol 1988 127 713 725 Search in Google Scholar

[131] Lundell M, Holm LE. Mortality from leukemia after irradiation in infancy for skin hemangioma. Radiat Res. 1996; 145: 595–601 LundellM HolmLE Mortality from leukemia after irradiation in infancy for skin hemangioma Radiat Res 1996 145 595 601 Search in Google Scholar

[132] Kheifets L, Repacholi M, Saunders R, van Deventer E. The sensitivity of children to electromagnetic fields. Pediatrics. 2005; 116: e303–313 KheifetsL RepacholiM SaundersR van DeventerE The sensitivity of children to electromagnetic fields Pediatrics 2005 116 e303 313 Search in Google Scholar

[133] Schuz J, Philipp J, Merzenich H, Schmiedel S, Bruggemeyer H. Re: “Radio-frequency radiation exposure from AM radio transmitters and childhood leukemia and brain cancer”. Am J Epidemiol. 2008; 167: 883–884 SchuzJ PhilippJ MerzenichH SchmiedelS BruggemeyerH Re: “Radio-frequency radiation exposure from AM radio transmitters and childhood leukemia and brain cancer” Am J Epidemiol 2008 167 883 884 Search in Google Scholar

[134] Repacholi M, Saunders R, van Deventer E, Kheifets L. Guest editors’ introduction: is EMF a potential environmental risk for children? Bioelectromagnetics. 2005; Suppl 7: S2–4 RepacholiM SaundersR van DeventerE KheifetsL Guest editors’ introduction: is EMF a potential environmental risk for children? Bioelectromagnetics 2005 Suppl 7 S2 4 Search in Google Scholar

[135] Hijiya N, Ness KK, Ribeiro RC, Hudson MM. Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues. Cancer. 2009; 115: 23–35 HijiyaN NessKK RibeiroRC HudsonMM Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues Cancer 2009 115 23 35 Search in Google Scholar

[136] Hawkins MM, Wilson LM, Stovall MA, Marsden HB, Potok MH, Kingston JE, Chessells JM. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ. 1992; 304: 951–958 HawkinsMM WilsonLM StovallMA MarsdenHB PotokMH KingstonJE ChessellsJM Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer BMJ 1992 304 951 958 Search in Google Scholar

[137] Le Deley MC, Leblanc T, Shamsaldin A, Raquin MA, Lacour B, Sommelet D, Chompret A, Cayuela JM, Bayle C, Bernheim A, et al. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d’Oncologie Pediatrique. J Clin Oncol. 2003; 21: 1074–1081 Le DeleyMC LeblancT ShamsaldinA RaquinMA LacourB SommeletD ChompretA CayuelaJM BayleC BernheimA Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d’Oncologie Pediatrique J Clin Oncol 2003 21 1074 1081 Search in Google Scholar